Overall, the CUPID-C trial corroborates earlier evidence that dupilumab can meaningfully reduce itch and hives in ...

(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

Unlike allergic hives, chronic spontaneous urticaria (CSU) stems from immune system dysregulation and can persist for months or years, requiring ongoing management. Patients should understand that CSU ...

Medically reviewed by Katlein Franca, MD Doctors use a process of elimination to diagnose chronic hives, rather than a single ...

Even though it happened about 15 years ago, I’ll never forget when the hives started to develop. I was working the midnight shift as a nurse, and sleeping during the day. It didn’t seem like a big ...

Chronic spontaneous urticaria (CSU) is responsible for 80% of all cases of chronic hives, but 90% of people never know what causes it. "A lot of times, patients want to know if something they're doing ...

This informational guide, part of PS's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to help.

Remibrutinib shows significant complete response rates across 3 chronic inducible urticaria subtypes in the phase 3 RemIND trial.

William Truswell, MD, FACS, operates his own cosmetic and reconstructive facial surgery practice. Dr. Truswell was the first in his area in Western Massachusetts to have an accredited private office ...

NVS wins CHMP backing for remibrutinib in chronic spontaneous urticaria, bringing its oral BTK inhibitor closer to EU approval.

Chronic urticaria is an inflammatory skin disorder characterised by recurrent transient wheals and/or angioedema that persist for more than six weeks. Within this spectrum, chronic spontaneous ...